This morning the 62nd session World Health Assembly agreed to a resolution on public health, innovation and intellectual property that, among other things, settled outstanding issues regarding the “stakeholders” for various parts of the Global Strategy and Plan of Action. (GS/PoA). With regard to the issue of a possible medical R&D treaty, the outcome of the negotiation was something of a split decision. On the one hand, the WHA agreed that the WHO would not be a stakeholder, in terms of the specific element of the WHO Global Strategy document.
The WHA will take up the WHA IGWG resolution at 9AM on Friday.
When discussing the issue of excluding the WHO from discussions about a medical R&D treaty, one PhRMA lobbyist told me “this was put to bed long ago.” He was in part referring to a WHO “green room” meeting that was organized before the Obama inauguration. One negotiator said the pharmaceutical companies are pressing hard to kill the medical R&D treaty here “before the new people take over.”
May 18, 2009
Open Letter to WHO Member States on outstanding components of Plan of Action on Public Health, Innovation and Intellectual Property
Dear WHO Member States,
During the 2008 World Heath Assembly WHO Member States reached unanimous consensus on resolution WHA 61.21 that adopted a Global Strategy and unfinished Plan of Action on Public Health, Innovation and Intellectual property.
On 23 May 2007, the 60th World Health Assembly, the World Health Organization’s highest governing body, adopted resolution WHA60.30 on Public health, innovation and intellectual property. This resolution bolstered the work program of WHO’s Intergovernmental Working Group on Public health, innovation and intellectual property (IGWG/PHI). This is the key operative section of the resolution, and the reactions by several key persons.
The final text of the resolution is here: